secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001104659-25-097138
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.01, 3.02, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics acquires GridAI in share exchange; former GridAI holders to own 82.5% of diluted ENTO
--------------------------------------------------------------------------------

- Acquired 100% of GridAI for 424,348 common shares (19.99% of outstanding) and 38,801,546 Series H convertible shares.
- Upon conversion (subject to shareholder approval), former GridAI stockholders will own 82.5% of ENTO on a fully diluted basis.
- GridAI is a grid-edge AI platform managing behind-the-meter assets; over $50M invested since 2019.
- ENTO must raise at least $3M in gross proceeds within 30 days post-closing and maintain $2M cash minimum.
- Former GridAI shareholders get right to designate 2 directors initially, eventually 5 of 7 board seats.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925097138/0001104659-25-097138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925097138/tm2528018d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-097138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer